DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: Q&A – China’s Proposed Tobacco Law Amendment” report has been added to ResearchAndMarkets.com’s offering.
The Ministry of Industry and Information Technology (MIIT) released the decision on amending the Regulations for the Implementation of the Law on Tobacco Monopoly of the People’s Republic of China at the end of March.
The draft amendment, which would regulate tobacco-alternative products – including e-cigarettes – as traditional tobacco, threatens big changes to the local vapour market.
Following conversations with several industry insiders and the local authorities, this report aims to provide a basic understanding of the recent developments in China. Which norms may be amended?
The Regulations for the Implementation of the Law on Tobacco Monopoly is the main piece of legislation currently being amended.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 What is the Proposed Regulatory Amendment?
4 Which Norms may be Amended?
5 What are ‘Other New Tobacco Products’?
6 What Would the Amendment Change for E-Cigs and Other Nicotine Products?
7 What About Technical Standards for E-Cigarettes?
8 What Do We Expect to Happen Next?
9 Is This a Positive or Negative Development?
10 Do We Expect Any Other Legal Developments?
For more information about this report visit https://www.researchandmarkets.com/r/u7p30g
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…
Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…
Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…
DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…
SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…
Itron and Cairns Regional Council Expand Collaboration on Water Security and Conservation LIBERTY LAKE, Wash.--(BUSINESS…